"This decision will be a major boost for many New Zealanders affected by endometriosis," says Tanya Cooke, Chief Executive of Endometriosis New Zealand. "For far too long, access to desogestrel, which ...

A randomized, double-blind study in 71 healthy female volunteers over 13 menstrual cycles showed that 75 micrograms of desogestrel daily inhibited ovulation in 97 percent of cycles compared to 71.9 ...